GlassScriptPhysician profile
Kevin David Dare
NPI 1942458773
$6,533.56
in general payments reported to CMS, 2019-2025
14 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,310 · 2020: $449 · 2021: $25.20 · 2022: $69.51 · 2023: $186 · 2024: $126 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,770.42 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $264.45 | 2024-2025 | Perclot, Tisseel |
| Smith+Nephew, INC. | $136.14 | 2019-2025 | Collagenase Santyl, Oasis |
| Allergan, INC. | $77.86 | 2019 | |
| Davol INC. | $69.06 | 2023 | Phasix Mesh |
| Medline Industries LP | $36.16 | 2019 | |
| Polynovo North America LLC | $30.43 | 2024 | Novosorb Btm |
| Tela Bio, INC. | $30.19 | 2024 | Ovitex 2s |
| Acera Surgical, INC. | $28.86 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $23.97 | 2025 | Transorb |
| Coopersurgical, INC. | $23.71 | 2024 | Insorb |
| Conmed Corporation | $18.39 | 2022 | |
| Kci USA, INC. | $12.84 | 2023 | Abthera, Prevena, V.A.C. Dermatac |
| Zyla Life Sciences, INC. | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Dare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.